|
|
Volumn 2, Issue 3, 2002, Pages 141-143
|
|
The challenges of delivering pharmacogenomics into clinical pediatrics
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
LAMOTRIGINE;
PSYCHOTROPIC AGENT;
VALPROIC ACID;
ARTICLE;
ATTENTION DEFICIT DISORDER;
AUTISM;
CHILD;
CHILDHOOD DISEASE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SAFETY;
GENETIC PREDISPOSITION;
HUMAN;
INFANT;
LIVER TOXICITY;
NEWBORN;
OBSESSION;
PATHOGENESIS;
PEDIATRICS;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
REYE SYNDROME;
SKIN DISEASE;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
DNA;
GENE EXPRESSION;
GENE THERAPY;
GENETICS, MEDICAL;
HUMAN GENOME PROJECT;
HUMANS;
INFANT;
INFANT, NEWBORN;
PEDIATRICS;
PHARMACOGENETICS;
UNITED STATES;
|
|
EID: 0036373274
PISSN: 1470269X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.tpj.6500104 Document Type: Article |
|
Times cited : (17)
|
|
References (21)
|
